These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3984005)

  • 1. Acute hemolysis and renal failure with rifampicin-dependent antibodies after discontinuous administration.
    Tahan SR; Diamond JR; Blank JM; Horan RF
    Transfusion; 1985; 25(2):124-7. PubMed ID: 3984005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG-mediated intravascular hemolysis and nonoliguric acute renal failure complicating discontinuous rifampicin administration.
    Diamond JR; Tahan SR
    Nephron; 1984; 38(1):62-4. PubMed ID: 6472533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin-associated acute renal failure and hemolysis: a rather uncommon but severe complication.
    Manika K; Tasiopoulou K; Vlogiaris L; Lada M; Papaemmanouil S; Zarogoulidis K; Kioumis I
    Ren Fail; 2013 Sep; 35(8):1179-81. PubMed ID: 23883374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoallergic complication induced by rifampicin with disseminated intravascular coagulation].
    Denis J; Robert A; Johanet C; Homberg JC; Opolon P; Levy VG
    Presse Med; 1983 May; 12(23):1479-81. PubMed ID: 6222344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features.
    De Vriese AS; Robbrecht DL; Vanholder RC; Vogelaers DP; Lameire NH
    Am J Kidney Dis; 1998 Jan; 31(1):108-15. PubMed ID: 9428460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review.
    Chiba S; Tsuchiya K; Sakashita H; Ito E; Inase N
    Intern Med; 2013; 52(21):2457-60. PubMed ID: 24190152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis.
    Murray AN; Cassidy MJ; Templecamp C
    Nephron; 1987; 46(4):373-6. PubMed ID: 3658067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute renal failure, intravascular hemolysis and toxic hepatitis caused by repeated use of rifampicin (case report)].
    Sefer S; Ivanusa M; Kes P; Ratković-Gusić I; Vasilj D
    Lijec Vjesn; 1999; 121(4-5):126-8. PubMed ID: 10437356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure caused by rifampicin re-exposure with 10-year of interval.
    Tsai TL; Lee CH; Chuang FR; Hsu KT
    Chang Gung Med J; 2001 Nov; 24(11):729-33. PubMed ID: 11820654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific features of acute renal failure in patients treated with rifampicin].
    Munteanu L; Golea O; Nicolicioiu M; Tudorache V
    Pneumologia; 2002; 51(1):15-20. PubMed ID: 12043271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune hemolytic anemia and acute kidney failure due to rifampicin].
    Guzzini F; Angiolini F; Cazzaniga L; Gasparini P; Milvio E; Mosconi L
    Recenti Prog Med; 1994 Mar; 85(3):182-5. PubMed ID: 8184201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin-induced immune thrombocytopenia.
    Blajchman MA; Lowry RC; Pettit JE; Stradling P
    Br Med J; 1970 Jul; 3(5713):24-6. PubMed ID: 5427483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-pathological features and possible pathogenesis of rifampicin-induced acute renal failure].
    Li X; Wang Y; Zhao M; Zhu Y; Liu Y; Wang H
    Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):370-3. PubMed ID: 11798598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune hemolytic anemia and renal failure associated with rifampicin-dependent antibodies with anti-I specificity.
    Pereira A; Sanz C; Cervantes F; Castillo R
    Ann Hematol; 1991 Jul; 63(1):56-8. PubMed ID: 1878425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemolysis and renal failure following discontinuous use of rifampin.
    Levine M; Collin K; Kassen BO
    DICP; 1991; 25(7-8):743-4. PubMed ID: 1949931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially serious side effects of high-dose twice-weekly rifampicin.
    Poole G; Stradling P; Worlledge S
    Br Med J; 1971 Aug; 3(5770):343-7. PubMed ID: 5314737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal failure complicating rifampicin therapy.
    Prakash J; Kumar NS; Saxena RK; Verma U
    J Assoc Physicians India; 2001 Sep; 49():877-80. PubMed ID: 11837753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antirifampicin antibodies in acute rifampicin-associated renal failure.
    Mauri JM; Fort J; Bartolome J; Camps J; Capdevila L; Morlans M; Martin-Vega C; Piera L
    Nephron; 1982; 31(2):177-9. PubMed ID: 7121659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of acute renal failure with hemolysis caused by readministration of rifampicin (author's transl)].
    Iida H; Takata M; Mizumura Y; Sugimoto T; Fujiki H
    Nihon Naika Gakkai Zasshi; 1981 Aug; 70(8):1137-41. PubMed ID: 7299234
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed hemolytic transfusion reaction caused by anti-P1 antibody.
    Chandeysson PL; Flye MW; Simpkins SM; Holland PV
    Transfusion; 1981; 21(1):77-82. PubMed ID: 7466910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.